
ESTA Stock Analysis
Establishment Labs Holdings Inc
HEALTHCARE
MEDICAL DEVICES
Performance Overview
Trailing adjusted-close returns as of 2026-07-07. Benchmark is SPY.
YTD Return
1-Year Return
3-Year Return
5-Year Return
Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.
Legacy Screening Checks
This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.
Looks for positive and improving earnings per share.
Looks for strong return on invested capital.
Checks whether operating income comfortably covers interest expense.
Checks whether free cash flow could pay down long-term debt quickly.
Checks whether valuation is reasonable under the current rule set.
Uses 20-day, 50-day, and 200-day moving averages for entry timing context.
Cached Technical Data
Moving average values from the latest stored scan.
Latest Published Stock Research
Research generated: October 24, 2026
ESTA Stock Analysis: Why Establishment Labs Holdings Inc Scored 37% in Stock Value Finder
Analyzing Establishment Labs Holdings Inc (ESTA): A Quantitative Research Review
This article provides a detailed educational research review of Establishment Labs Holdings Inc (ESTA), conducted via the StockValueFinder methodology. The purpose of this report is to dissect the specific financial metrics and quantitative signals associated with ESTA to help investors understand how fundamental data points interact to form a complete picture of a company's financial health. This is not a recommendation to purchase or liquidate a position; rather, it is an educational breakdown of the data as recorded by our analytical systems.
Overview of Establishment Labs Holdings Inc (ESTA)
Establishment Labs Holdings Inc (Ticker: ESTA) operates within the Healthcare sector, specifically focusing on the Medical Devices industry. In the medical device landscape, companies often face high research and development costs, significant regulatory hurdles, and capital-intensive manufacturing processes. These factors can lead to volatile earnings profiles and complex balance sheets.
As of the most recent data, ESTA is trading at a price of $63.80. When evaluating a company in this sector, an investor must look beyond the product offerings and scrutinize how efficiently the company manages its capital, handles its debt, and generates actual profit for its shareholders. This review will use the specific metrics provided by our system to evaluate whether ESTA meets the rigorous standards of value-oriented, hard-money investing.
Why the StockValueFinder Score Matters
The StockValueFinder score for Establishment Labs Holdings Inc is 37%. Based on this quantitative assessment, the current rating is AVOID.
It is important to understand what a score represents. The StockValueFinder score is a composite metric that aggregates various fundamental tests, including profitability, valuation, debt management, and trend analysis. A score of 100% would represent a company that passes every single metric with high margins of safety. Conversely, a score of 37% indicates that the company has failed several critical tests required to meet our criteria for a high-quality, value-oriented investment.
In the context of long-term investing, a low score often signals that the company is currently facing headwinds related to profitability or financial stability. For an investor, a low score serves as a warning to look closer at the underlying numbers before considering any exposure to the equity.
EPS Strength and Consistency
Earnings Per Share (EPS) is a fundamental metric used to determine how much profit a company makes for each outstanding share of common stock. Consistency in EPS is vital because it demonstrates a company's ability to generate repeatable, predictable cash flows—the bedrock of long-term purchasing power.
Regarding the EPS test for ESTA, the system recorded a result of "Did not pass." While the specific historical EPS values were not supplied in this data set, the failure of the test indicates that the company's earnings history does not meet the required thresholds for stability or positive growth as defined by our screening parameters.
To learn how to evaluate other stocks, consider this example: A company that shows a steady increase in EPS over five years (e.g., $1.00, $1.20, $1.40) demonstrates high earnings quality. A company with highly erratic or negative EPS suggests a business model that is still in a volatile phase or struggling to achieve profitability. Because ESTA failed this test, it lacks the earnings consistency that value-oriented investors typically seek to mitigate long-term uncertainty.
ROIC and Capital Efficiency
Return on Invested Capital (ROIC) is one of the most critical metrics for assessing how effectively a management team uses the money it has raised to generate returns. It measures the profit a company generates relative to the total capital (both debt and equity) invested in the business.
The supplied ROIC for ESTA is -17.73%.
In a healthy, value-driven environment, StockValueFinder generally prefers an ROIC of 10% or higher. A positive ROIC suggests that the company is creating value; a negative ROIC suggests that the company is actually destroying capital as it operates.
To illustrate this for your own research
From a hard-money perspective, negative ROIC is a significant red flag. It implies that the more the company grows or expands, the more capital it may consume without a corresponding increase in profitable output, which can lead to increased dilution or higher debt loads.
Interest Coverage and Financial Safety
Interest coverage is a solvency ratio that measures how easily a company can pay interest on its outstanding debt using its current earnings. This is a vital metric for assessing "safety" in an environment of fluctuating interest rates and potential currency instability.
The system recorded that ESTA "Did not pass" the interest coverage test.
StockValueFinder prefers an interest coverage ratio of 6 or higher. This provides a "cushion" so that if earnings temporarily dip, the company can still meet its contractual obligations to lenders.
For example
Failing this test suggests that ESTA may face significant pressure if its cash flows tighten or if it needs to refinance debt in a higher-interest-rate environment.
Debt Payback and Balance Sheet Discipline
Debt payback (often expressed in years) estimates how long it would take a company to pay back its total debt if it used all its available cash flow. This metric is essential for understanding the long-term sustainability of a company's balance sheet.
The supplied debt payback value for ESTA is -4.30 years.
StockValueFinder prefers a debt payback period of 3 years or less. A lower number indicates that the company can clear its obligations quickly, leaving more capital available for reinvestment or shareholder returns.
Example
The negative value of -4.30 years for ESTA is an anomaly that indicates the current mathematical relationship between its debt and cash flow does not support a standard positive payback period. This reinforces the "Avoid" rating, as it points to significant uncertainty regarding the company's ability to clear its liabilities through organic operations.
P/E Ratio and Valuation Discipline
The Price-to-Earnings (P/E) ratio is a valuation metric that compares the current share price to its per-share earnings. It tells an investor how much they are paying for every $1 of profit.
The supplied P/E ratio for ESTA is -36.67.
While the system marked the P/E valuation test as "Passed," this must be interpreted carefully in the context of a negative number. In many screening models, if a company is not currently profitable (as indicated by the negative EPS and ROIC), the P/E ratio becomes a mathematical abstraction. StockValueFinder prefers a P/E of 15 or lower for strict valuation discipline to ensure investors are not overpaying for growth that may never materialize.
Example
Even though the test was technically "passed" (likely due to how the algorithm handles negative earnings in its specific logic), a negative P/E remains a signal that there is no current "earnings" to buy, which is a fundamental concern for value-seeking investors.
Moving Average Trend and Entry Timing
Technical indicators like moving averages are used to identify the current direction of a stock's price movement. This is used for timing discipline rather than as a fundamental proof of value.
The moving average signal for ESTA is "SELL / AVOID TREND." Additionally, the entry signal is listed as "N/A."
A "Sell / Avoid Trend" indicates that the stock's price is currently moving downward or failing to maintain upward momentum relative to its historical averages. For an investor, this suggests that even if the fundamental value were attractive, the current momentum is working against the position.
It is important to note that "N/A" status for the Limit Buy Idea, Pullback Zone, and Risk Stop / Trend Risk Level means there are no specific price targets provided by the system at this time. These fields are intended to provide educational reference levels for where an investor might look for entries or exits, but they are not orders to trade.
Overall Financial Strengths and Weaknesses
In summary, the quantitative profile of Establishment Labs Holdings Inc (ESTA) reveals several critical areas of concern:
**Strengths:** - The company has passed the Debt Payback test and P/E valuation test within the specific parameters of the StockValueFinder algorithm, though these must be viewed alongside the negative underlying values.
**Weaknesses:** - **Profitability:** The company failed the EPS test and has a negative ROIC of -17.73%, indicating it is currently consuming capital rather than generating it. - **Solvency:** The company failed the interest coverage test, suggesting potential difficulty in managing debt obligations. - **Momentum:** The moving average signal is a "SELL / AVOID TREND," indicating downward price pressure. - **Overall Score:** The 37% score and "AVOID" rating reflect a lack of the fundamental stability required for a high-conviction value investment.
Risks and Limitations
Investors should be aware that all quantitative analysis is based on historical data and current mathematical models. These models cannot predict sudden shifts in government regulation, changes in healthcare policy, or unexpected macroeconomic shocks such as rapid inflation or currency devaluation.
Furthermore, a company in the medical device industry may undergo periods of heavy loss while developing new technology. However, from a hard-money perspective, the inability to demonstrate current profitability and capital efficiency increases the risk of purchasing power erosion if the company requires further capital raises through equity dilution.
Educational Conclusion
Through this research of ESTA, we can observe how different metrics paint a cohesive picture. A company might have a "passed" valuation test, but if its ROIC is negative and its interest coverage is insufficient, the "value" may be a trap. High-quality investing requires looking for the intersection of reasonable valuation, positive earnings consistency, and efficient capital use. ESTA currently fails to meet these combined criteria according to the StockValueFinder metrics.
This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.
Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings
30-Day Trendline Analysis
Optional intraday chart with rising support, falling resistance, and multi-timeframe views.